These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 16736496)

  • 1. Assessment of gene promoter hypermethylation for detection of cervical neoplasia.
    Wisman GB; Nijhuis ER; Hoque MO; Reesink-Peters N; Koning AJ; Volders HH; Buikema HJ; Boezen HM; Hollema H; Schuuring E; Sidransky D; van der Zee AG
    Int J Cancer; 2006 Oct; 119(8):1908-14. PubMed ID: 16736496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detecting cervical cancer by quantitative promoter hypermethylation assay on cervical scrapings: a feasibility study.
    Reesink-Peters N; Wisman GB; Jéronimo C; Tokumaru CY; Cohen Y; Dong SM; Klip HG; Buikema HJ; Suurmeijer AJ; Hollema H; Boezen HM; Sidransky D; van der Zee AG
    Mol Cancer Res; 2004 May; 2(5):289-95. PubMed ID: 15192122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The RASSF1A tumor suppressor gene is commonly inactivated in adenocarcinoma of the uterine cervix.
    Cohen Y; Singer G; Lavie O; Dong SM; Beller U; Sidransky D
    Clin Cancer Res; 2003 Aug; 9(8):2981-4. PubMed ID: 12912945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of RAS association domain family 1A gene in cervical carcinomas and the role of human papillomavirus infection.
    Kuzmin I; Liu L; Dammann R; Geil L; Stanbridge EJ; Wilczynski SP; Lerman MI; Pfeifer GP
    Cancer Res; 2003 Apr; 63(8):1888-93. PubMed ID: 12702579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative assessment of DNA methylation for the detection of cervical and endometrial adenocarcinomas in liquid-based cytology specimens.
    Kim GE; Kweon SS; Lee JS; Lee JH; Nam JH; Choi C
    Anal Quant Cytopathol Histpathol; 2012 Aug; 34(4):195-203. PubMed ID: 23016466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative analysis of the relationship between microRNA‑124a, -34b and -203 gene methylation and cervical oncogenesis.
    Botezatu A; Goia-Rusanu CD; Iancu IV; Huica I; Plesa A; Socolov D; Ungureanu C; Anton G
    Mol Med Rep; 2011; 4(1):121-8. PubMed ID: 21461574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between RASSF1A Promoter Hypermethylation and Oncogenic HPV Infection Status in Invasive Cervical Cancer: a Meta-analysis.
    Li JY; Huang T; Zhang C; Jiang DJ; Hong QX; Ji HH; Ye M; Duan SW
    Asian Pac J Cancer Prev; 2015; 16(14):5749-54. PubMed ID: 26320446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a multiplex methylation-specific PCR as candidate triage test for women with an HPV-positive cervical scrape.
    Snellenberg S; De Strooper LM; Hesselink AT; Meijer CJ; Snijders PJ; Heideman DA; Steenbergen RD
    BMC Cancer; 2012 Nov; 12():551. PubMed ID: 23176198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus DNA in uterine cervix squamous cell carcinoma and adenocarcinoma detected by polymerase chain reaction.
    Iwasawa A; Nieminen P; Lehtinen M; Paavonen J
    Cancer; 1996 Jun; 77(11):2275-9. PubMed ID: 8635095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypermethylation of the tumor suppressor gene RASSFIA and frequent concomitant loss of heterozygosity at 3p21 in cervical cancers.
    Yu MY; Tong JH; Chan PK; Lee TL; Chan MW; Chan AW; Lo KW; To KF
    Int J Cancer; 2003 Jun; 105(2):204-9. PubMed ID: 12673680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative assessment of DNA methylation for the detection of cervical neoplasia in liquid-based cytology specimens.
    Kim JH; Choi YD; Lee JS; Lee JH; Nam JH; Choi C; Kweon SS; Fackler MJ; Sukumar S
    Virchows Arch; 2010 Jul; 457(1):35-42. PubMed ID: 20496080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of cervical cancer precursor lesions by quantitative methylation specific PCR: A retrospective study.
    Al Roomy M; Chehadeh W; Al Awadhi R
    Cytopathology; 2023 May; 34(3):204-210. PubMed ID: 36715362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of DNA hypermethylation patterns in different types of uterine cancer: cervical squamous cell carcinoma, cervical adenocarcinoma and endometrial adenocarcinoma.
    Kang S; Kim JW; Kang GH; Lee S; Park NH; Song YS; Park SY; Kang SB; Lee HP
    Int J Cancer; 2006 May; 118(9):2168-71. PubMed ID: 16331610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repression of MAL tumour suppressor activity by promoter methylation during cervical carcinogenesis.
    Overmeer RM; Henken FE; Bierkens M; Wilting SM; Timmerman I; Meijer CJ; Snijders PJ; Steenbergen RD
    J Pathol; 2009 Nov; 219(3):327-36. PubMed ID: 19662663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
    Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
    BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for cervical neoplasia in Denmark.
    Kjaer SK
    APMIS Suppl; 1998; 80():1-41. PubMed ID: 9693662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated levels of tetraploid cervical cells in human papillomavirus-positive Papanicolaou smears diagnosed as atypical squamous cells of undetermined significance.
    Olaharski AJ; Eastmond DA
    Cancer; 2004 Jun; 102(3):192-9. PubMed ID: 15211479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The relationship with human papilloma virus DNA in cervical adenocarcinoma].
    Ogura K; Ishi K; Suzuki F; Suto H; Kina K; Koyatsu J; Nojima M; Yoshida K; Suda K
    Rinsho Byori; 2004 Feb; 52(2):115-9. PubMed ID: 15027314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inverse correlation between RASSF1A hypermethylation, KRAS and BRAF mutations in cervical adenocarcinoma.
    Kang S; Kim HS; Seo SS; Park SY; Sidransky D; Dong SM
    Gynecol Oncol; 2007 Jun; 105(3):662-6. PubMed ID: 17360030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer.
    Wallin KL; Wiklund F; Angström T; Bergman F; Stendahl U; Wadell G; Hallmans G; Dillner J
    N Engl J Med; 1999 Nov; 341(22):1633-8. PubMed ID: 10572150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.